| Year |
Citation |
Score |
| 2014 |
Marshall GM, Patarachao B, Moran K, Mercier PHJ. Zircon mineral solids concentrated from Athabasca oil sands froth treatment tailings: Surface chemistry and flotation properties Minerals Engineering. 65: 79-87. DOI: 10.1016/J.Mineng.2014.05.016 |
0.403 |
|
| 2014 |
Marshall GM, Kingston DM, Moran K, Mercier PHJ. Multivariate factor analysis of heavy minerals concentrate from Athabasca oil sands tailings by X-ray photoelectron spectroscopy Surface and Interface Analysis. 46: 197-209. DOI: 10.1002/Sia.5201 |
0.319 |
|
| 2012 |
Arudra P, Marshall GM, Liu N, Dubowski JJ. Enhanced photonic stability of GaAs in aqueous electrolyte using alkanethiol self-assembled monolayers and postprocessing with ammonium sulfide Journal of Physical Chemistry C. 116: 2891-2895. DOI: 10.1021/Jp208604V |
0.59 |
|
| 2011 |
Marshall GM, Lopinski GP, Bensebaa F, Dubowski JJ. Electro-optic investigation of the surface trapping efficiency in n-alkanethiol SAM passivated GaAs(001). Nanotechnology. 22: 235704. PMID 21490389 DOI: 10.1088/0957-4484/22/23/235704 |
0.626 |
|
| 2011 |
Marshall GM, Bensebaa F, Dubowski JJ. Surface barrier analysis of semi-insulating and n+-type GaAs(0 0 1) following passivation with n-alkanethiol SAMs Applied Surface Science. 257: 4543-4546. DOI: 10.1016/J.Apsusc.2010.12.084 |
0.629 |
|
| 2010 |
Dubowski JJ, Voznyy O, Marshall GM. Molecular self-assembly and passivation of GaAs (0 0 1) with alkanethiol monolayers: A view towards bio-functionalization Applied Surface Science. 256: 5714-5721. DOI: 10.1016/J.Apsusc.2010.03.090 |
0.635 |
|
| 2009 |
Marshall GM, Lopinski GP, Bensebaa F, Dubowski JJ. Surface dipole layer potential induced ir absorption enhancement in n-alkanethiol SAMs on GaAs(001). Langmuir : the Acs Journal of Surfaces and Colloids. 25: 13561-8. PMID 19874009 DOI: 10.1021/La901888Q |
0.627 |
|
| 2009 |
Kim CK, Marshall GM, Martin M, Bisson-Viens M, Wasilewski Z, Dubowski JJ. Formation dynamics of hexadecanethiol self-assembled monolayers on (001) GaAs observed with photoluminescence and Fourier transform infrared spectroscopies Journal of Applied Physics. 106. DOI: 10.1063/1.3248370 |
0.622 |
|
| 2009 |
Marshall GM, Bensebaa F, Dubowski JJ. Observation of surface enhanced IR absorption coefficient in alkanethiol based self-assembled monolayers on GaAs(001) Journal of Applied Physics. 105. DOI: 10.1063/1.3122052 |
0.628 |
|
| 1999 |
Dubowski J, Poole P, Sproule G, Marshall G, Moisa S, Lacelle C, Buchanan M. Enhanced quantum-well photoluminescence in InGaAs/InGaAsP heterostructures following excimer-laser-assisted surface processing Applied Physics a: Materials Science & Processing. 69: S299-S303. DOI: 10.1007/S003390051404 |
0.514 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2014 |
Bensebaa F, Di Domenicantonio D, Scoles L, Kingston D, Mercier P, Marshall G. Alternative coating technologies for metal–ceramic nanocomposite films: potential application for solar thermal absorber International Journal of Low-Carbon Technologies. 11: 370-374. DOI: 10.1093/Ijlct/Ctt081 |
0.248 |
|
| 2009 |
Thomas WD, Chen J, Gao YR, Cheung B, Koach J, Sekyere E, Norris MD, Haber M, Ellis T, Wainwright B, Marshall GM. Patched1 deletion increases N-Myc protein stability as a mechanism of medulloblastoma initiation and progression. Oncogene. 28: 1605-15. PMID 19234491 DOI: 10.1038/onc.2009.3 |
0.172 |
|
| 2011 |
Marshall GM, Liu PY, Gherardi S, Scarlett CJ, Bedalov A, Xu N, Iraci N, Valli E, Ling D, Thomas W, van Bekkum M, Sekyere E, Jankowski K, Trahair T, Mackenzie KL, et al. SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability. Plos Genetics. 7: e1002135. PMID 21698133 DOI: 10.1371/Journal.Pgen.1002135 |
0.168 |
|
| 2015 |
Sun Y, Bell JL, Carter DR, Gherardi S, Poulos RC, Milazzo G, Wong JW, Al-Awar R, Tee AE, Liu PY, Liu B, Atmadibrata B, Wong M, Trahair T, Zhao Q, ... ... Marshall GM, et al. WDR5 supports an N-Myc transcriptional complex that drives a pro-tumorigenic gene expression signature in neuroblastoma. Cancer Research. PMID 26471359 DOI: 10.1158/0008-5472.Can-15-0423 |
0.143 |
|
| 2014 |
Shahbazi J, Scarlett CJ, Norris MD, Liu B, Haber M, Tee AE, Carrier A, Biankin AV, London WB, Marshall GM, Lock RB, Liu T. Histone deacetylase 2 and N-Myc reduce p53 protein phosphorylation at serine 46 by repressing gene transcription of tumor protein 53-induced nuclear protein 1. Oncotarget. 5: 4257-68. PMID 24952595 DOI: 10.18632/Oncotarget.1991 |
0.142 |
|
| 2014 |
Sun Y, Liu PY, Scarlett CJ, Malyukova A, Liu B, Marshall GM, MacKenzie KL, Biankin AV, Liu T. Histone deacetylase 5 blocks neuroblastoma cell differentiation by interacting with N-Myc. Oncogene. 33: 2987-94. PMID 23812427 DOI: 10.1038/Onc.2013.253 |
0.142 |
|
| 2007 |
Liu T, Tee AE, Porro A, Smith SA, Dwarte T, Liu PY, Iraci N, Sekyere E, Haber M, Norris MD, Diolaiti D, Della Valle G, Perini G, Marshall GM. Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis. Proceedings of the National Academy of Sciences of the United States of America. 104: 18682-7. PMID 18003922 DOI: 10.1073/Pnas.0705524104 |
0.141 |
|
| 2012 |
Fletcher JI, Gherardi S, Murray J, Burkhart CA, Russell A, Valli E, Smith J, Oberthuer A, Ashton LJ, London WB, Marshall GM, Norris MD, Perini G, Haber M. N-Myc regulates expression of the detoxifying enzyme glutathione transferase GSTP1, a marker of poor outcome in neuroblastoma. Cancer Research. 72: 845-53. PMID 22202125 DOI: 10.1158/0008-5472.CAN-11-1885 |
0.139 |
|
| 2010 |
Marshall GM, Gherardi S, Xu N, Neiron Z, Trahair T, Scarlett CJ, Chang DK, Liu PY, Jankowski K, Iraci N, Haber M, Norris MD, Keating J, Sekyere E, Jonquieres G, et al. Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects. Oncogene. 29: 5957-68. PMID 20697349 DOI: 10.1038/Onc.2010.332 |
0.13 |
|
| 2014 |
Tee AE, Ling D, Nelson C, Atmadibrata B, Dinger ME, Xu N, Mizukami T, Liu PY, Liu B, Cheung B, Pasquier E, Haber M, Norris MD, Suzuki T, Marshall GM, et al. The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1. Oncotarget. 5: 1793-804. PMID 24742640 DOI: 10.18632/Oncotarget.1785 |
0.126 |
|
| 2013 |
Liu PY, Xu N, Malyukova A, Scarlett CJ, Sun YT, Zhang XD, Ling D, Su SP, Nelson C, Chang DK, Koach J, Tee AE, Haber M, Norris MD, Toon C, ... ... Marshall GM, et al. The histone deacetylase SIRT2 stabilizes Myc oncoproteins. Cell Death and Differentiation. 20: 503-14. PMID 23175188 DOI: 10.1038/cdd.2012.147 |
0.123 |
|
| 2014 |
Atmadibrata B, Liu PY, Sokolowski N, Zhang L, Wong M, Tee AE, Marshall GM, Liu T. The novel long noncoding RNA linc00467 promotes cell survival but is down-regulated by N-Myc. Plos One. 9: e88112. PMID 24586304 DOI: 10.1371/Journal.Pone.0088112 |
0.122 |
|
| 2014 |
Liu PY, Erriquez D, Marshall GM, Tee AE, Polly P, Wong M, Liu B, Bell JL, Zhang XD, Milazzo G, Cheung BB, Fox A, Swarbrick A, Hüttelmaier S, Kavallaris M, et al. Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression. Journal of the National Cancer Institute. 106. PMID 24906397 DOI: 10.1093/Jnci/Dju113 |
0.102 |
|
| 2004 |
Manohar CF, Bray JA, Salwen HR, Madafiglio J, Cheng A, Flemming C, Marshall GM, Norris MD, Haber M, Cohn SL. MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma. Oncogene. 23: 753-62. PMID 14737110 DOI: 10.1038/sj.onc.1207151 |
0.094 |
|
| 2016 |
Shahbazi J, Liu PY, Atmadibrata B, Bradner JE, Marshall GM, Lock RB, Liu T. The bromodomain inhibitor JQ1 and the histone deacetylase inhibitor panobinostat synergistically reduce N-Myc expression and induce anticancer effects. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26733615 DOI: 10.1158/1078-0432.Ccr-15-1666 |
0.094 |
|
| 2013 |
Malyukova A, Brown S, Papa R, O'Brien R, Giles J, Trahair TN, Dalla Pozza L, Sutton R, Liu T, Haber M, Norris MD, Lock RB, Sangfelt O, Marshall GM. FBXW7 regulates glucocorticoid response in T-cell acute lymphoblastic leukaemia by targeting the glucocorticoid receptor for degradation. Leukemia. 27: 1053-62. PMID 23228967 DOI: 10.1038/Leu.2012.361 |
0.094 |
|
| 2009 |
Sutton R, Venn NC, Tolisano J, Bahar AY, Giles JE, Ashton LJ, Teague L, Rigutto G, Waters K, Marshall GM, Haber M, Norris MD. Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia. British Journal of Haematology. 146: 292-9. PMID 19500099 DOI: 10.1111/j.1365-2141.2009.07744.x |
0.093 |
|
| 2015 |
Lau DT, Flemming CL, Gherardi S, Perini G, Oberthuer A, Fischer M, Juraeva D, Brors B, Xue C, Norris MD, Marshall GM, Haber M, Fletcher JI, Ashton LJ. MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastoma. Oncotarget. 6: 15510-23. PMID 25860940 |
0.09 |
|
| 2008 |
Ong V, Liem NL, Schmid MA, Verrills NM, Papa RA, Marshall GM, Mackenzie KL, Kavallaris M, Lock RB. A role for altered microtubule polymer levels in vincristine resistance of childhood acute lymphoblastic leukemia xenografts. The Journal of Pharmacology and Experimental Therapeutics. 324: 434-42. PMID 17986648 DOI: 10.1124/jpet.107.128926 |
0.089 |
|
| 2008 |
Henderson MJ, Choi S, Beesley AH, Sutton R, Venn NC, Marshall GM, Kees UR, Haber M, Norris MD. Mechanism of relapse in pediatric acute lymphoblastic leukemia. Cell Cycle (Georgetown, Tex.). 7: 1315-20. PMID 18418081 DOI: 10.4161/cc.7.10.5885 |
0.089 |
|
| 2010 |
Porro A, Haber M, Diolaiti D, Iraci N, Henderson M, Gherardi S, Valli E, Munoz MA, Xue C, Flemming C, Schwab M, Wong JH, Marshall GM, Della Valle G, Norris MD, et al. Direct and coordinate regulation of ATP-binding cassette transporter genes by Myc factors generates specific transcription signatures that significantly affect the chemoresistance phenotype of cancer cells. The Journal of Biological Chemistry. 285: 19532-43. PMID 20233711 DOI: 10.1074/jbc.M109.078584 |
0.088 |
|
| 2016 |
Sutton SK, Carter DR, Kim P, Tan O, Arndt GM, Zhang XD, Baell J, Noll BD, Wang S, Kumar N, McArthur GA, Cheung BB, Marshall GM. A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner. Oncotarget. PMID 27447557 DOI: 10.18632/Oncotarget.10700 |
0.087 |
|
| 2005 |
Ziegler DS, Dalla Pozza L, Waters KD, Marshall GM. Advances in childhood leukaemia: successful clinical-trials research leads to individualised therapy. The Medical Journal of Australia. 182: 78-81. PMID 15651967 |
0.087 |
|
| 2012 |
Ling D, Marshall GM, Liu PY, Xu N, Nelson CA, Iismaa SE, Liu T. Enhancing the anticancer effect of the histone deacetylase inhibitor by activating transglutaminase. European Journal of Cancer (Oxford, England : 1990). 48: 3278-87. PMID 22459762 DOI: 10.1016/J.Ejca.2012.02.067 |
0.086 |
|
| 2009 |
Burkhart CA, Watt F, Murray J, Pajic M, Prokvolit A, Xue C, Flemming C, Smith J, Purmal A, Isachenko N, Komarov PG, Gurova KV, Sartorelli AC, Marshall GM, Norris MD, et al. Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma. Cancer Research. 69: 6573-80. PMID 19654298 DOI: 10.1158/0008-5472.Can-09-1075 |
0.085 |
|
| 2010 |
Tee AE, Marshall GM, Liu PY, Xu N, Haber M, Norris MD, Iismaa SE, Liu T. Opposing effects of two tissue transglutaminase protein isoforms in neuroblastoma cell differentiation. The Journal of Biological Chemistry. 285: 3561-7. PMID 20007697 DOI: 10.1074/Jbc.M109.053041 |
0.085 |
|
| 2015 |
Moradi Manesh D, El-Hoss J, Evans K, Richmond J, Toscan CE, Bracken LS, Hedrick A, Sutton R, Marshall GM, Wilson WR, Kurmasheva RT, Billups C, Houghton PJ, Smith MA, Carol H, et al. AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia. Blood. PMID 26116659 DOI: 10.1182/blood-2014-12-618900 |
0.082 |
|
| 2010 |
Balamuth NJ, Wood A, Wang Q, Jagannathan J, Mayes P, Zhang Z, Chen Z, Rappaport E, Courtright J, Pawel B, Weber B, Wooster R, Sekyere EO, Marshall GM, Maris JM. Serial transcriptome analysis and cross-species integration identifies centromere-associated protein E as a novel neuroblastoma target. Cancer Research. 70: 2749-58. PMID 20233875 DOI: 10.1158/0008-5472.Can-09-3844 |
0.081 |
|
| 2009 |
Brisco MJ, Latham S, Sutton R, Hughes E, Wilczek V, van Zanten K, Budgen B, Bahar AY, Malec M, Sykes PJ, Kuss BJ, Waters K, Venn NC, Giles JE, Haber M, ... ... Marshall GM, et al. Determining the repertoire of IGH gene rearrangements to develop molecular markers for minimal residual disease in B-lineage acute lymphoblastic leukemia. The Journal of Molecular Diagnostics : Jmd. 11: 194-200. PMID 19324994 DOI: 10.2353/jmoldx.2009.080047 |
0.081 |
|
| 2016 |
Carter DR, Sutton SK, Pajic M, Murray J, Sekyere EO, Fletcher J, Beckers A, De Preter K, Speleman F, George RE, Haber M, Norris MD, Cheung BB, Marshall GM. Glutathione biosynthesis is upregulated at the initiation of MYCN-driven neuroblastoma tumorigenesis. Molecular Oncology. PMID 26996379 DOI: 10.1016/j.molonc.2016.02.004 |
0.08 |
|
| 2015 |
Nowak D, Liem NL, Mossner M, Klaumünzer M, Papa RA, Nowak V, Jann JC, Akagi T, Kawamata N, Okamoto R, Thoennissen NH, Kato M, Sanada M, Hofmann WK, Ogawa S, ... Marshall GM, et al. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance. Experimental Hematology. 43: 32-43.e1-35. PMID 25450514 DOI: 10.1016/J.Exphem.2014.09.007 |
0.08 |
|
| 2015 |
Sutton R, Shaw PJ, Venn NC, Law T, Dissanayake A, Kilo T, Haber M, Norris MD, Fraser C, Alvaro F, Revesz T, Trahair TN, Dalla-Pozza L, Marshall GM, O'Brien TA. Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia. British Journal of Haematology. 168: 395-404. PMID 25312094 DOI: 10.1111/bjh.13142 |
0.079 |
|
| 2014 |
Kim PY, Tan O, Diakiw SM, Carter D, Sekerye EO, Wasinger VC, Liu T, Kavallaris M, Norris MD, Haber M, Chesler L, Dolnikov A, Trahair TN, Cheung NK, Marshall GM, et al. Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach. Journal of Proteomics. 96: 1-12. PMID 24200836 DOI: 10.1016/J.Jprot.2013.10.032 |
0.079 |
|
| 2010 |
Bachmann PS, Piazza RG, Janes ME, Wong NC, Davies C, Mogavero A, Bhadri VA, Szymanska B, Geninson G, Magistroni V, Cazzaniga G, Biondi A, Miranda-Saavedra D, Göttgens B, Saffery R, ... ... Marshall GM, et al. Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition. Blood. 116: 3013-22. PMID 20647567 DOI: 10.1182/blood-2010-05-284968 |
0.079 |
|
| 2016 |
Xue C, Yu DM, Gherardi S, Koach J, Milazzo G, Gamble L, Liu B, Valli E, Russell AJ, London WB, Liu T, Cheung BB, Marshall GM, Perini G, Haber M, et al. MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4. Oncotarget. PMID 27448979 DOI: 10.18632/Oncotarget.10709 |
0.078 |
|
| 2015 |
Cheung BB, Tan O, Koach J, Liu B, Shum MS, Carter DR, Sutton S, Po'uha ST, Chesler L, Haber M, Norris MD, Kavallaris M, Liu T, O'Neill GM, Marshall GM. Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma. Molecular Oncology. 9: 1484-500. PMID 25963741 DOI: 10.1016/J.Molonc.2015.04.005 |
0.078 |
|
| 2003 |
Cheung B, Yan J, Smith SA, Nguyen T, Lee M, Kavallaris M, Norris MD, Haber M, Marshall GM. Growth inhibitory retinoid effects after recruitment of retinoid X receptor beta to the retinoic acid receptor beta promoter. International Journal of Cancer. Journal International Du Cancer. 105: 856-67. PMID 12767074 DOI: 10.1002/ijc.11153 |
0.078 |
|
| 2007 |
Choi S, Henderson MJ, Kwan E, Beesley AH, Sutton R, Bahar AY, Giles J, Venn NC, Pozza LD, Baker DL, Marshall GM, Kees UR, Haber M, Norris MD. Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone. Blood. 110: 632-9. PMID 17371950 DOI: 10.1182/blood-2007-01-067785 |
0.078 |
|
| 2010 |
Marshall GM, Bell JL, Koach J, Tan O, Kim P, Malyukova A, Thomas W, Sekyere EO, Liu T, Cunningham AM, Tobias V, Norris MD, Haber M, Kavallaris M, Cheung BB. TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells. Oncogene. 29: 6172-83. PMID 20729920 DOI: 10.1038/Onc.2010.340 |
0.077 |
|
| 2005 |
Hansford LM, Marshall GM. Glial cell line-derived neurotrophic factor (GDNF) family ligands reduce the sensitivity of neuroblastoma cells to pharmacologically induced cell death, growth arrest and differentiation. Neuroscience Letters. 389: 77-82. PMID 16125842 DOI: 10.1016/j.neulet.2005.07.034 |
0.077 |
|
| 2009 |
Liu T, Liu PY, Tee AE, Haber M, Norris MD, Gleave ME, Marshall GM. Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitors. European Journal of Cancer (Oxford, England : 1990). 45: 1846-54. PMID 19342222 DOI: 10.1016/J.Ejca.2009.03.002 |
0.076 |
|
| 2015 |
Carter DR, Murray J, Cheung BB, Gamble L, Koach J, Tsang J, Sutton S, Kalla H, Syed S, Gifford AJ, Issaeva N, Biktasova A, Atmadibrata B, Sun Y, Sokolowski N, ... ... Marshall GM, et al. Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma. Science Translational Medicine. 7: 312ra176. PMID 26537256 DOI: 10.1126/Scitranslmed.Aab1803 |
0.076 |
|
| 2006 |
Liu T, Kuljaca S, Tee A, Marshall GM. Histone deacetylase inhibitors: multifunctional anticancer agents. Cancer Treatment Reviews. 32: 157-65. PMID 16516391 DOI: 10.1016/J.Ctrv.2005.12.006 |
0.075 |
|
| 2011 |
Bayes R, Bueno JF, Hillairet A, Davydov YI, Depommier P, Faszer W, Gagliardi CA, Gaponenko A, Gill DR, Grossheim A, Gumplinger P, Hasinoff MD, Henderson RS, Hu J, Koetke DD, ... ... Marshall GM, et al. Experimental constraints on left-right symmetric models from muon decay. Physical Review Letters. 106: 041804. PMID 21405321 DOI: 10.1103/Physrevlett.106.041804 |
0.073 |
|
| 2011 |
Cheung BB, Marshall GM. Targeting ATP7A to increase the sensitivity of neuroblastoma cells to retinoid therapy. Current Cancer Drug Targets. 11: 826-36. PMID 21762080 DOI: 10.2174/156800911796798968 |
0.072 |
|
| 2009 |
Liu T, Liu PY, Marshall GM. The critical role of the class III histone deacetylase SIRT1 in cancer. Cancer Research. 69: 1702-5. PMID 19244112 DOI: 10.1158/0008-5472.Can-08-3365 |
0.072 |
|
| 2014 |
Sutton SK, Koach J, Tan O, Liu B, Carter DR, Wilmott JS, Yosufi B, Haydu LE, Mann GJ, Thompson JF, Long GV, Liu T, McArthur G, Zhang XD, Scolyer RA, ... ... Marshall GM, et al. TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells. Oncotarget. 5: 10127-39. PMID 25333256 DOI: 10.18632/Oncotarget.2466 |
0.072 |
|
| 2005 |
Norris MD, Smith J, Tanabe K, Tobin P, Flemming C, Scheffer GL, Wielinga P, Cohn SL, London WB, Marshall GM, Allen JD, Haber M. Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro. Molecular Cancer Therapeutics. 4: 547-53. PMID 15827327 DOI: 10.1158/1535-7163.MCT-04-0161 |
0.072 |
|
| 2009 |
Bohlken A, Cheung BB, Bell JL, Koach J, Smith S, Sekyere E, Thomas W, Norris M, Haber M, Lovejoy DB, Richardson DR, Marshall GM. ATP7A is a novel target of retinoic acid receptor beta2 in neuroblastoma cells. British Journal of Cancer. 100: 96-105. PMID 19127267 DOI: 10.1038/sj.bjc.6604833 |
0.072 |
|
| 2010 |
Bell E, Chen L, Liu T, Marshall GM, Lunec J, Tweddle DA. MYCN oncoprotein targets and their therapeutic potential. Cancer Letters. 293: 144-57. PMID 20153925 DOI: 10.1016/J.Canlet.2010.01.015 |
0.071 |
|
| 2012 |
Cheung BB, Koach J, Tan O, Kim P, Bell JL, D'andreti C, Sutton S, Malyukova A, Sekyere E, Norris M, Haber M, Kavallaris M, Cunningham AM, Proby C, Leigh I, ... ... Marshall GM, et al. The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro. The Journal of Pathology. 226: 451-62. PMID 22009481 DOI: 10.1002/path.2986 |
0.069 |
|
| 2007 |
Bachmann PS, Gorman R, Papa RA, Bardell JE, Ford J, Kees UR, Marshall GM, Lock RB. Divergent mechanisms of glucocorticoid resistance in experimental models of pediatric acute lymphoblastic leukemia. Cancer Research. 67: 4482-90. PMID 17483364 DOI: 10.1158/0008-5472.CAN-06-4244 |
0.069 |
|
| 2013 |
Bell JL, Malyukova A, Kavallaris M, Marshall GM, Cheung BB. TRIM16 inhibits neuroblastoma cell proliferation through cell cycle regulation and dynamic nuclear localization. Cell Cycle (Georgetown, Tex.). 12: 889-98. PMID 23422002 DOI: 10.4161/cc.23825 |
0.068 |
|
| 2013 |
Calao M, Sekyere EO, Cui HJ, Cheung BB, Thomas WD, Keating J, Chen JB, Raif A, Jankowski K, Davies NP, Bekkum MV, Chen B, Tan O, Ellis T, Norris MD, ... ... Marshall GM, et al. Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation. Oncogene. 32: 3616-26. PMID 22907436 DOI: 10.1038/Onc.2012.368 |
0.068 |
|
| 2005 |
Kavallaris M, Marshall GM. Proteomics and disease: opportunities and challenges. The Medical Journal of Australia. 182: 575-9. PMID 15938685 |
0.068 |
|
| 2016 |
Bingul M, Tan O, Gardner CR, Sutton SK, Arndt GM, Marshall GM, Cheung BB, Kumar N, Black DS. Synthesis, Characterization and Anti-Cancer Activity of Hydrazide Derivatives Incorporating a Quinoline Moiety. Molecules (Basel, Switzerland). 21. PMID 27428941 DOI: 10.3390/Molecules21070916 |
0.067 |
|
| 2003 |
Burkhart CA, Cheng AJ, Madafiglio J, Kavallaris M, Mili M, Marshall GM, Weiss WA, Khachigian LM, Norris MD, Haber M. Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma. Journal of the National Cancer Institute. 95: 1394-403. PMID 13130115 DOI: 10.1093/Jnci/Djg045 |
0.067 |
|
| 2009 |
Raif A, Marshall GM, Bell JL, Koach J, Tan O, D'andreti C, Thomas W, Sekyere E, Norris M, Haber M, Kavallaris M, Cheung BB. The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoid-resistant cancer cells via effects on histone acetylation. Cancer Letters. 277: 82-90. PMID 19147277 DOI: 10.1016/j.canlet.2008.11.030 |
0.067 |
|
| 2016 |
Tee AE, Liu B, Song R, Li J, Pasquier E, Cheung BB, Jiang C, Marshall GM, Haber M, Norris MD, Fletcher JI, Dinger ME, Liu T. The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expression. Oncotarget. PMID 26848616 DOI: 10.18632/Oncotarget.6675 |
0.067 |
|
| 2003 |
Hansford LM, Smith SA, Haber M, Norris MD, Cheung B, Marshall GM. Cloning and characterization of the human neural cell adhesion molecule, CNTN4 (alias BIG-2). Cytogenetic and Genome Research. 101: 17-23. PMID 14571131 DOI: 10.1159/000073412 |
0.067 |
|
| 2016 |
Richmond J, Robbins A, Evans K, Beck D, Kurmasheva RT, Billups CA, Carol H, Heatley S, Sutton R, Marshall GM, White D, Pimanda J, Houghton PJ, Smith MA, Lock RB. Acute sensitivity of Ph-like acute lymphoblastic leukemia to the SMAC-mimetic birinapant. Cancer Research. PMID 27302164 DOI: 10.1158/0008-5472.Can-16-0523 |
0.066 |
|
| 2022 |
Wen J, Patel C, Diglio F, Baker K, Marshall G, Li S, Cole PD. Cognitive impairment persists at least 1 year after juvenile rats are treated with methotrexate. Neuropharmacology. 206: 108939. PMID 34986414 DOI: 10.1016/j.neuropharm.2021.108939 |
0.066 |
|
| 2009 |
Kuljaca S, Liu T, Dwarte T, Kavallaris M, Haber M, Norris MD, Martin-Caballero J, Marshall GM. The cyclin-dependent kinase inhibitor, p21(WAF1), promotes angiogenesis by repressing gene transcription of thioredoxin-binding protein 2 in cancer cells. Carcinogenesis. 30: 1865-71. PMID 19773351 DOI: 10.1093/Carcin/Bgp225 |
0.065 |
|
| 2007 |
Cheng AJ, Cheng NC, Ford J, Smith J, Murray JE, Flemming C, Lastowska M, Jackson MS, Hackett CS, Weiss WA, Marshall GM, Kees UR, Norris MD, Haber M. Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma. European Journal of Cancer (Oxford, England : 1990). 43: 1467-75. PMID 17449239 DOI: 10.1016/J.Ejca.2007.03.008 |
0.065 |
|
| 2016 |
Evageliou NF, Haber M, Vu A, Laetsch TW, Murray J, Gamble LD, Cheng NC, Liu K, Reese M, Corrigan KA, Ziegler DS, Webber HT, Hayes CS, Pawel BR, Marshall GM, et al. Polyamine antagonist therapies inhibit neuroblastoma initiation and progression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27012811 DOI: 10.1158/1078-0432.Ccr-15-2539 |
0.064 |
|
| 2013 |
Karsa M, Dalla Pozza L, Venn NC, Law T, Shi R, Giles JE, Bahar AY, Cross S, Catchpoole D, Haber M, Marshall GM, Norris MD, Sutton R. Improving the identification of high risk precursor B acute lymphoblastic leukemia patients with earlier quantification of minimal residual disease. Plos One. 8: e76455. PMID 24146872 DOI: 10.1371/journal.pone.0076455 |
0.064 |
|
| 2008 |
Hogarty MD, Norris MD, Davis K, Liu X, Evageliou NF, Hayes CS, Pawel B, Guo R, Zhao H, Sekyere E, Keating J, Thomas W, Cheng NC, Murray J, Smith J, ... ... Marshall GM, et al. ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma. Cancer Research. 68: 9735-45. PMID 19047152 DOI: 10.1158/0008-5472.Can-07-6866 |
0.063 |
|
| 2007 |
Xue C, Haber M, Flemming C, Marshall GM, Lock RB, MacKenzie KL, Gurova KV, Norris MD, Gudkov AV. p53 determines multidrug sensitivity of childhood neuroblastoma. Cancer Research. 67: 10351-60. PMID 17974978 DOI: 10.1158/0008-5472.Can-06-4345 |
0.063 |
|
| 2012 |
Gardner CR, Cheung BB, Koach J, Black DS, Marshall GM, Kumar N. Synthesis of retinoid enhancers based on 2-aminobenzothiazoles for anti-cancer therapy. Bioorganic & Medicinal Chemistry. 20: 6877-84. PMID 23088909 DOI: 10.1016/J.Bmc.2012.09.035 |
0.062 |
|
| 2013 |
Kim PY, Rahmanto AS, Tan O, Norris MD, Haber M, Marshall GM, Cheung BB. TRIM16 overexpression induces apoptosis through activation of caspase-2 in cancer cells. Apoptosis : An International Journal On Programmed Cell Death. 18: 639-51. PMID 23404198 DOI: 10.1007/s10495-013-0813-y |
0.061 |
|
| 2013 |
Marshall GM, Dalla Pozza L, Sutton R, Ng A, de Groot-Kruseman HA, van der Velden VH, Venn NC, van den Berg H, de Bont ES, Maarten Egeler R, Hoogerbrugge PM, Kaspers GJ, Bierings MB, van der Schoot E, van Dongen J, et al. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation. Leukemia. 27: 1497-503. PMID 23407458 DOI: 10.1038/leu.2013.44 |
0.059 |
|
| 2005 |
Musser JR, Bayes R, Davydov YI, Depommier P, Doornbos J, Faszer W, Gagliardi CA, Gaponenko A, Gill DR, Green P, Gumplinger P, Hasinoff MD, Henderson RS, Hu J, Jamieson B, ... ... Marshall GM, et al. Measurement of the Michel parameter rho in muon decay. Physical Review Letters. 94: 101805. PMID 15783475 DOI: 10.1103/Physrevlett.94.101805 |
0.059 |
|
| 2004 |
Hansford LM, Thomas WD, Keating JM, Burkhart CA, Peaston AE, Norris MD, Haber M, Armati PJ, Weiss WA, Marshall GM. Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification. Proceedings of the National Academy of Sciences of the United States of America. 101: 12664-9. PMID 15314226 DOI: 10.1073/Pnas.0401083101 |
0.056 |
|
| 2005 |
Liu T, Bohlken A, Kuljaca S, Lee M, Nguyen T, Smith S, Cheung B, Norris MD, Haber M, Holloway AJ, Bowtell DD, Marshall GM. The retinoid anticancer signal: mechanisms of target gene regulation. British Journal of Cancer. 93: 310-8. PMID 16012519 DOI: 10.1038/Sj.Bjc.6602700 |
0.056 |
|
| 2014 |
Samuels AL, Beesley AH, Yadav BD, Papa RA, Sutton R, Anderson D, Marshall GM, Cole CH, Kees UR, Lock RB. A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia. Blood Cancer Journal. 4: e232. PMID 25083816 DOI: 10.1038/bcj.2014.52 |
0.055 |
|
| 2014 |
Marshall GM, Carter DR, Cheung BB, Liu T, Mateos MK, Meyerowitz JG, Weiss WA. The prenatal origins of cancer. Nature Reviews. Cancer. 14: 277-89. PMID 24599217 DOI: 10.1038/Nrc3679 |
0.055 |
|
| 2014 |
Saletta F, Wadham C, Ziegler DS, Marshall GM, Haber M, McCowage G, Norris MD, Byrne JA. Molecular profiling of childhood cancer: Biomarkers and novel therapies. Bba Clinical. 1: 59-77. PMID 26675306 DOI: 10.1016/j.bbacli.2014.06.003 |
0.055 |
|
| 2008 |
Sutton R, Bahar AY, Kwan E, Giles JE, Venn NC, Tran S, Hackenberg N, Pozza LD, Marshall GM, Haber M, van der Velden VH, Norris MD. Improving minimal residual disease detection in precursor B-ALL based on immunoglobulin-kappa and heavy-chain gene rearrangements. Leukemia. 22: 2265-7. PMID 18496559 DOI: 10.1038/leu.2008.121 |
0.054 |
|
| 2011 |
Henderson MJ, Haber M, Porro A, Munoz MA, Iraci N, Xue C, Murray J, Flemming CL, Smith J, Fletcher JI, Gherardi S, Kwek CK, Russell AJ, Valli E, London WB, ... ... Marshall GM, et al. ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux. Journal of the National Cancer Institute. 103: 1236-51. PMID 21799180 DOI: 10.1093/Jnci/Djr256 |
0.054 |
|
| 2006 |
Haber M, Smith J, Bordow SB, Flemming C, Cohn SL, London WB, Marshall GM, Norris MD. Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 1546-53. PMID 16575006 DOI: 10.1200/JCO.2005.01.6196 |
0.054 |
|
| 2015 |
Beckers A, Van Peer G, Carter DR, Gartlgruber M, Herrmann C, Agarwal S, Helsmoortel HH, Althoff K, Molenaar JJ, Cheung BB, Schulte JH, Benoit Y, Shohet JM, Westermann F, Marshall GM, et al. MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma. Cancer Letters. 366: 123-32. PMID 26123663 DOI: 10.1016/j.canlet.2015.06.015 |
0.052 |
|
| 2016 |
Kim PY, Tan O, Liu B, Trahair T, Liu T, Haber M, Norris MD, Marshall GM, Cheung BB. High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients. Cancer Letters. PMID 26902425 DOI: 10.1016/J.Canlet.2016.02.021 |
0.052 |
|
| 2006 |
Cheung BB, Bell J, Raif A, Bohlken A, Yan J, Roediger B, Poljak A, Smith S, Lee M, Thomas WD, Kavallaris M, Norris M, Haber M, Liu HL, Zajchowski D, ... Marshall GM, et al. The estrogen-responsive B box protein is a novel regulator of the retinoid signal. The Journal of Biological Chemistry. 281: 18246-56. PMID 16636064 DOI: 10.1074/jbc.M600879200 |
0.052 |
|
| 2007 |
Kuljaca S, Liu T, Tee AE, Haber M, Norris MD, Dwarte T, Marshall GM. Enhancing the anti-angiogenic action of histone deacetylase inhibitors. Molecular Cancer. 6: 68. PMID 17958916 DOI: 10.1186/1476-4598-6-68 |
0.051 |
|
| 2005 |
Laughton SJ, Ashton LJ, Kwan E, Norris MD, Haber M, Marshall GM. Early responses to chemotherapy of normal and malignant hematologic cells are prognostic in children with acute lymphoblastic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 2264-71. PMID 15800317 DOI: 10.1200/JCO.2005.04.012 |
0.05 |
|
| 2006 |
Verrills NM, Po'uha ST, Liu ML, Liaw TY, Larsen MR, Ivery MT, Marshall GM, Gunning PW, Kavallaris M. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia. Journal of the National Cancer Institute. 98: 1363-74. PMID 17018783 DOI: 10.1093/jnci/djj372 |
0.049 |
|
| 2023 |
Zeren N, Afzal Z, Morgan S, Marshall G, Uppiliappan M, Merritt J, Coniglio SJ. The Chemokine Receptor CCR1 Mediates Microglia Stimulated Glioma Invasion. International Journal of Molecular Sciences. 24. PMID 36982211 DOI: 10.3390/ijms24065136 |
0.048 |
|
| 2012 |
Venn NC, van der Velden VH, de Bie M, Waanders E, Giles JE, Law T, Kuiper RP, de Haas V, Mullighan CG, Haber M, Marshall GM, Md N, van Dongen JJ, Sutton R. Highly sensitive MRD tests for ALL based on the IKZF1 Δ3-6 microdeletion. Leukemia. 26: 1414-6. PMID 22157735 DOI: 10.1038/leu.2011.348 |
0.048 |
|
| 2012 |
Lau DT, Hesson LB, Norris MD, Marshall GM, Haber M, Ashton LJ. Prognostic significance of promoter DNA methylation in patients with childhood neuroblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5690-700. PMID 22929802 DOI: 10.1158/1078-0432.CCR-12-0294 |
0.046 |
|
| 2006 |
Chen KA, Laywell ED, Marshall G, Walton N, Zheng T, Steindler DA. Fusion of neural stem cells in culture. Experimental Neurology. 198: 129-35. PMID 16406350 DOI: 10.1016/J.Expneurol.2005.11.016 |
0.046 |
|
| 2011 |
Barbaro PM, Johnston K, Dalla-Pozza L, Cohn RJ, Wang YA, Marshall GM, Ziegler DS. Reduced incidence of second solid tumors in survivors of childhood Hodgkin's lymphoma treated without radiation therapy. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 22: 2569-74. PMID 21393381 DOI: 10.1093/annonc/mdr013 |
0.046 |
|
| 2015 |
Mateos MK, Barbaric D, Byatt SA, Sutton R, Marshall GM. Down syndrome and leukemia: insights into leukemogenesis and translational targets. Translational Pediatrics. 4: 76-92. PMID 26835364 DOI: 10.3978/j.issn.2224-4336.2015.03.03 |
0.044 |
|
| 2007 |
Trahair TN, Vowels MR, Johnston K, Cohn RJ, Russell SJ, Neville KA, Carroll S, Marshall GM. Long-term outcomes in children with high-risk neuroblastoma treated with autologous stem cell transplantation. Bone Marrow Transplantation. 40: 741-6. PMID 17724446 DOI: 10.1038/sj.bmt.1705809 |
0.04 |
|
| 2009 |
Ashton LJ, Gifford AJ, Kwan E, Lingwood A, Lau DT, Marshall GM, Haber M, Norris MD. Reduced folate carrier and methylenetetrahydrofolate reductase gene polymorphisms: associations with clinical outcome in childhood acute lymphoblastic leukemia. Leukemia. 23: 1348-51. PMID 19340000 DOI: 10.1038/leu.2009.67 |
0.04 |
|
| 2012 |
Bell JL, Malyukova A, Holien JK, Koach J, Parker MW, Kavallaris M, Marshall GM, Cheung BB. TRIM16 acts as an E3 ubiquitin ligase and can heterodimerize with other TRIM family members. Plos One. 7: e37470. PMID 22629402 DOI: 10.1371/journal.pone.0037470 |
0.038 |
|
| 2023 |
Marshall G, Cao J. Mechanism-directed combinational immunotherapies in liver cancer hold promise. Cellular & Molecular Immunology. PMID 37544963 DOI: 10.1038/s41423-023-01068-z |
0.037 |
|
| 2011 |
Pajic M, Murray J, Marshall GM, Cole SP, Norris MD, Haber M. ABCC1 G2012T single nucleotide polymorphism is associated with patient outcome in primary neuroblastoma and altered stability of the ABCC1 gene transcript. Pharmacogenetics and Genomics. 21: 270-9. PMID 21317832 DOI: 10.1097/FPC.0b013e328343dd5f |
0.035 |
|
| 2015 |
Beckers A, Van Peer G, Carter DR, Mets E, Althoff K, Cheung BB, Schulte JH, Mestdagh P, Vandesompele J, Marshall GM, De Preter K, Speleman F. MYCN-targeting miRNAs are predominantly downregulated during MYCN‑driven neuroblastoma tumor formation. Oncotarget. 6: 5204-16. PMID 25294817 |
0.034 |
|
| 2013 |
Mateos MK, O'Brien TA, Oswald C, Gabriel M, Ziegler DS, Cohn RJ, Russell SJ, Barbaric D, Marshall GM, Trahair TN. Transplant-related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25-year retrospective review. Pediatric Blood & Cancer. 60: 1520-7. PMID 23733511 DOI: 10.1002/pbc.24559 |
0.03 |
|
| 2011 |
Lau DT, Norris MD, Marshall GM, Haber M, Ashton LJ. HLA-G polymorphisms, genetic susceptibility, and clinical outcome in childhood neuroblastoma. Tissue Antigens. 78: 421-7. PMID 22115424 DOI: 10.1111/j.1399-0039.2011.01781.x |
0.028 |
|
| 2012 |
Bhadri VA, Beckett SM, Duncan C, Marshall GM, Ashton LJ. Variation in Toll-like receptor 9 gene modifies the risk of infection in children treated for acute lymphoblastic leukemia. Leukemia & Lymphoma. 53: 1828-30. PMID 22288832 DOI: 10.3109/10428194.2012.661858 |
0.027 |
|
| 2009 |
Satharasinghe K, Trahair TN, Barbaric D, O'Brien TA, Russell SJ, Cohn RJ, Marshall GM, Ziegler DS. False-positive MIBG scans with normal computed tomography imaging in patients with high-risk neuroblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e233-4; author reply. PMID 19884537 DOI: 10.1200/JCO.2009.24.0036 |
0.027 |
|
| 2007 |
Ashton LJ, Murray JE, Haber M, Marshall GM, Ashley DM, Norris MD. Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastoma. Pharmacogenetics and Genomics. 17: 709-17. PMID 17700360 DOI: 10.1097/FPC.0b013e3280e1cc92 |
0.025 |
|
| 2014 |
Bailey HD, Miller M, Greenop KR, Bower C, Attia J, Marshall GM, Armstrong BK, Milne E. Paternal intake of folate and vitamins B6 and B12 before conception and risk of childhood acute lymphoblastic leukemia. Cancer Causes & Control : Ccc. 25: 1615-25. PMID 25281326 DOI: 10.1007/s10552-014-0466-3 |
0.025 |
|
| 2010 |
Milne E, Royle JA, Miller M, Bower C, de Klerk NH, Bailey HD, van Bockxmeer F, Attia J, Scott RJ, Norris MD, Haber M, Thompson JR, Fritschi L, Marshall GM, Armstrong BK. Maternal folate and other vitamin supplementation during pregnancy and risk of acute lymphoblastic leukemia in the offspring. International Journal of Cancer. Journal International Du Cancer. 126: 2690-9. PMID 19839053 DOI: 10.1002/ijc.24969 |
0.021 |
|
| 2008 |
Marsh DJ, Trahair TN, Martin JL, Chee WY, Walker J, Kirk EP, Baxter RC, Marshall GM. Rapamycin treatment for a child with germline PTEN mutation. Nature Clinical Practice. Oncology. 5: 357-61. PMID 18431376 DOI: 10.1038/ncponc1112 |
0.02 |
|
| 2004 |
Kirk EP, Smith JM, Field M, Marshall GM, Marsh DJ. Diagnosis of Proteus syndrome was correct. American Journal of Medical Genetics. Part A. 130: 214-5; author reply . PMID 15372511 DOI: 10.1002/ajmg.a.30337 |
0.011 |
|
| 2010 |
Bhadri VA, McGregor MR, Venn NC, Hackenberg N, Russell SJ, Norris MD, Haber M, Sutton R, Marshall GM. Isolated testicular relapse after allo-SCT in boys with ALL: outcome without second transplant. Bone Marrow Transplantation. 45: 397-9. PMID 19543328 DOI: 10.1038/bmt.2009.138 |
0.01 |
|
| Hide low-probability matches. |